5-HT₃ receptors in Parkinson's disease psychosis: a forgotten target?

Neurodegener Dis Manag. 2019 Oct;9(5):251-253. doi: 10.2217/nmt-2019-0014.

Authors

Cynthia Kwan¹, Philippe Huot^{1

2

3}

Affiliations

¹ Neurodegenerative Disease Group, Montreal Neurological Institute, H3A 2B4 Montreal, QC, Canada.
² Department of Neurology & Neurosurgery, McGill University, H3A 2B4 Montreal, QC, Canada.
³ Department of Neuroscience, McGill University Health Centre, H3A 2B4 Montreal, QC, Canada.

PMID: 31580227
DOI: 10.2217/nmt-2019-0014

No abstract available

Keywords: 5-HT3 receptors; Parkinson’s disease; psychosis; serotonin.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antipsychotic Agents / therapeutic use*
Humans
Ondansetron / therapeutic use*
Parkinson Disease / complications*
Psychotic Disorders / drug therapy*
Psychotic Disorders / etiology*
Receptors, Serotonin, 5-HT3 / drug effects*
Serotonin 5-HT3 Receptor Antagonists / therapeutic use*

Substances

Antipsychotic Agents
Receptors, Serotonin, 5-HT3
Serotonin 5-HT3 Receptor Antagonists
Ondansetron